CALTERIDOL CALCIUM

Details

Stereochemistry	RACEMIC
Molecular Formula	2C17H29N4O7.3Ca
Molecular Weight	923.104
Optical Activity	( + / - )
Defined Stereocenters	0 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Ca++].[Ca++].[Ca++].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1.CC(O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2

InChI

InChIKey=LIUKFIPDXXYGSI-UHFFFAOYSA-H

InChI=1S/2C17H32N4O7.3Ca/c2*1-14(22)10-18-2-4-19(11-15(23)24)6-8-21(13-17(27)28)9-7-20(5-3-18)12-16(25)26;;;/h2*14,22H,2-13H2,1H3,(H,23,24)(H,25,26)(H,27,28);;;/q;;3*+2/p-6

HIDE SMILES / InChI

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19981217&CC=WO&NR=9856776A1&KC=A1 | http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=%2720100226943%27.PGNR.&OS=DN/20100226943&RS=DN/20100226943

Calteridol is tetraazacyclododecane-1,4,7-triacetic acid derivative patented by Bracco and Dibra S.P.A.

Originator

Approval Year

Patents

Name

Type

Language

CALTERIDOL CALCIUM

Official Name

English

CALCIATE(1-), (10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-)-N(SUP 1),N(SUP 4,N(SUP 7),N(SUP 10),O(SUP 1),O(SUP 4),O(SUP 7),O(SUP 10))-, CALCIUM (2:1)

Common Name

English

(±)-CALCIUM BIS((10-(2-HYDROXYPROPYL)-1,4,7,10-TETRAAZACYCLODODECANE-1,4,7-TRIACETATO(3-))CALCIATE(1-))

Common Name

English

CALTERIDOL CALCIUM [II]

Common Name

English

SQ 33,248

Code

English

CALTERIDOL CALCIUM [USAN]

Common Name

English

Calteridol calcium [WHO-DD]

Common Name

English

SQ-33248

Code

English

CALTERIDOL CALCIUM [VANDF]

Common Name

English

Code System Code Type Description

EVMPD

SUB13208MIG